ketotifen has been researched along with Gastric Diseases in 2 studies
Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karmeli, F | 1 |
| Eliakim, R | 1 |
| Okon, E | 1 |
| Rachmilewitz, D | 1 |
| Rydning, A | 1 |
| Lyng, O | 1 |
| Adamsen, BL | 1 |
| Falkmer, S | 1 |
| Sandvik, AK | 1 |
| Grønbech, JE | 1 |
2 other studies available for ketotifen and Gastric Diseases
| Article | Year |
|---|---|
Role of vasoactive intestinal peptide (VIP) in pathogenesis of ethanol-induced gastric mucosal damage in rats.
Topics: Acute Disease; Animals; Drug Interactions; Ethanol; Gastric Mucosa; Ketotifen; Leukotrienes; Male; R | 1993 |
Mast cells are involved in the gastric hyperemic response to acid back diffusion via release of histamine.
Topics: Acids; Animals; Cell Count; Diffusion; Gastric Mucosa; Histamine H1 Antagonists; Histamine Release; | 2001 |